nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—ABCB1—Mitomycin—stomach cancer	0.168	0.336	CbGbCtD
Epinastine—CYP2B6—Irinotecan—stomach cancer	0.0841	0.168	CbGbCtD
Epinastine—HRH2—gastric juice—stomach cancer	0.0526	0.244	CbGeAlD
Epinastine—CYP2B6—Doxorubicin—stomach cancer	0.046	0.0918	CbGbCtD
Epinastine—ABCB1—Irinotecan—stomach cancer	0.0431	0.0862	CbGbCtD
Epinastine—ABCB1—Docetaxel—stomach cancer	0.0316	0.0632	CbGbCtD
Epinastine—CYP3A4—Irinotecan—stomach cancer	0.0258	0.0516	CbGbCtD
Epinastine—ABCB1—Doxorubicin—stomach cancer	0.0236	0.0471	CbGbCtD
Epinastine—ABCB1—Methotrexate—stomach cancer	0.0228	0.0456	CbGbCtD
Epinastine—CYP2D6—Doxorubicin—stomach cancer	0.0222	0.0444	CbGbCtD
Epinastine—HTR7—myenteric nerve plexus—stomach cancer	0.0215	0.1	CbGeAlD
Epinastine—CYP3A4—Docetaxel—stomach cancer	0.0189	0.0378	CbGbCtD
Epinastine—HTR7—vagus nerve—stomach cancer	0.0144	0.0667	CbGeAlD
Epinastine—CYP3A4—Doxorubicin—stomach cancer	0.0141	0.0282	CbGbCtD
Epinastine—HTR7—vein—stomach cancer	0.0139	0.0645	CbGeAlD
Epinastine—HTR2A—myenteric nerve plexus—stomach cancer	0.0134	0.0624	CbGeAlD
Epinastine—HTR2A—vagus nerve—stomach cancer	0.00896	0.0416	CbGeAlD
Epinastine—HTR2A—vein—stomach cancer	0.00866	0.0402	CbGeAlD
Epinastine—Lacrimation increased—Floxuridine—stomach cancer	0.00757	0.101	CcSEcCtD
Epinastine—HRH2—hematopoietic system—stomach cancer	0.00461	0.0214	CbGeAlD
Epinastine—HTR7—blood vessel—stomach cancer	0.00441	0.0205	CbGeAlD
Epinastine—Pharyngitis—Floxuridine—stomach cancer	0.00348	0.0463	CcSEcCtD
Epinastine—HRH2—digestive system—stomach cancer	0.00321	0.0149	CbGeAlD
Epinastine—HTR2A—blood vessel—stomach cancer	0.00275	0.0128	CbGeAlD
Epinastine—Eye irritation—Fluorouracil—stomach cancer	0.00267	0.0355	CcSEcCtD
Epinastine—HRH2—endocrine gland—stomach cancer	0.00265	0.0123	CbGeAlD
Epinastine—Cough increased—Irinotecan—stomach cancer	0.0026	0.0346	CcSEcCtD
Epinastine—Lacrimation increased—Irinotecan—stomach cancer	0.00258	0.0344	CcSEcCtD
Epinastine—Infection—Floxuridine—stomach cancer	0.00247	0.0329	CcSEcCtD
Epinastine—Lacrimation increased—Fluorouracil—stomach cancer	0.00247	0.0329	CcSEcCtD
Epinastine—HRH2—liver—stomach cancer	0.00239	0.0111	CbGeAlD
Epinastine—HTR7—hematopoietic system—stomach cancer	0.00235	0.0109	CbGeAlD
Epinastine—ADRA1A—hematopoietic system—stomach cancer	0.00226	0.0105	CbGeAlD
Epinastine—HTR7—epithelium—stomach cancer	0.00214	0.00996	CbGeAlD
Epinastine—Cough—Mitomycin—stomach cancer	0.00209	0.0278	CcSEcCtD
Epinastine—ADRA1A—epithelium—stomach cancer	0.00207	0.00961	CbGeAlD
Epinastine—HTR7—smooth muscle tissue—stomach cancer	0.00207	0.0096	CbGeAlD
Epinastine—Mianserin—HRH4—stomach cancer	0.00197	0.19	CrCbGaD
Epinastine—Eye irritation—Docetaxel—stomach cancer	0.00193	0.0256	CcSEcCtD
Epinastine—Eye irritation—Capecitabine—stomach cancer	0.00186	0.0248	CcSEcCtD
Epinastine—HRH2—lymph node—stomach cancer	0.00183	0.00851	CbGeAlD
Epinastine—ABCB1—blood vessel—stomach cancer	0.0018	0.00836	CbGeAlD
Epinastine—CYP2B6—hematopoietic system—stomach cancer	0.00179	0.00833	CbGeAlD
Epinastine—Lacrimation increased—Docetaxel—stomach cancer	0.00178	0.0238	CcSEcCtD
Epinastine—HRH1—hematopoietic system—stomach cancer	0.00175	0.00813	CbGeAlD
Epinastine—Lacrimation increased—Capecitabine—stomach cancer	0.00173	0.023	CcSEcCtD
Epinastine—ADRA2A—hematopoietic system—stomach cancer	0.00172	0.00799	CbGeAlD
Epinastine—HTR7—digestive system—stomach cancer	0.00163	0.00758	CbGeAlD
Epinastine—HRH1—epithelium—stomach cancer	0.0016	0.00744	CbGeAlD
Epinastine—ADRA1A—lymphoid tissue—stomach cancer	0.00159	0.0074	CbGeAlD
Epinastine—Headache—Floxuridine—stomach cancer	0.00156	0.0208	CcSEcCtD
Epinastine—HRH1—smooth muscle tissue—stomach cancer	0.00154	0.00716	CbGeAlD
Epinastine—Nasopharyngitis—Fluorouracil—stomach cancer	0.00148	0.0197	CcSEcCtD
Epinastine—HTR2A—hematopoietic system—stomach cancer	0.00146	0.00679	CbGeAlD
Epinastine—ADRA2A—pancreas—stomach cancer	0.0014	0.00651	CbGeAlD
Epinastine—Upper respiratory tract infection—Irinotecan—stomach cancer	0.00139	0.0185	CcSEcCtD
Epinastine—CYP3A4—hematopoietic system—stomach cancer	0.00135	0.00629	CbGeAlD
Epinastine—HTR7—endocrine gland—stomach cancer	0.00135	0.00626	CbGeAlD
Epinastine—HTR2A—epithelium—stomach cancer	0.00134	0.00621	CbGeAlD
Epinastine—CYP2D6—hematopoietic system—stomach cancer	0.00133	0.00619	CbGeAlD
Epinastine—Upper respiratory tract infection—Fluorouracil—stomach cancer	0.00133	0.0177	CcSEcCtD
Epinastine—ADRA1A—endocrine gland—stomach cancer	0.0013	0.00604	CbGeAlD
Epinastine—HTR2A—smooth muscle tissue—stomach cancer	0.00129	0.00598	CbGeAlD
Epinastine—CYP2B6—lymphoid tissue—stomach cancer	0.00126	0.00586	CbGeAlD
Epinastine—CYP2B6—digestive system—stomach cancer	0.00125	0.00579	CbGeAlD
Epinastine—Headache—Mitomycin—stomach cancer	0.00122	0.0163	CcSEcCtD
Epinastine—Amitriptyline—HRH4—stomach cancer	0.00122	0.118	CrCbGaD
Epinastine—HRH1—digestive system—stomach cancer	0.00122	0.00566	CbGeAlD
Epinastine—HTR7—liver—stomach cancer	0.00122	0.00564	CbGeAlD
Epinastine—Cough increased—Epirubicin—stomach cancer	0.00121	0.0161	CcSEcCtD
Epinastine—Lacrimation increased—Epirubicin—stomach cancer	0.0012	0.016	CcSEcCtD
Epinastine—Rhinitis—Irinotecan—stomach cancer	0.0012	0.0159	CcSEcCtD
Epinastine—Sinusitis—Fluorouracil—stomach cancer	0.0012	0.0159	CcSEcCtD
Epinastine—ADRA1A—liver—stomach cancer	0.00117	0.00544	CbGeAlD
Epinastine—Rhinitis—Fluorouracil—stomach cancer	0.00115	0.0153	CcSEcCtD
Epinastine—Pharyngitis—Fluorouracil—stomach cancer	0.00114	0.0151	CcSEcCtD
Epinastine—Cough increased—Doxorubicin—stomach cancer	0.00112	0.0149	CcSEcCtD
Epinastine—Lacrimation increased—Doxorubicin—stomach cancer	0.00111	0.0148	CcSEcCtD
Epinastine—Nasopharyngitis—Docetaxel—stomach cancer	0.00107	0.0142	CcSEcCtD
Epinastine—Nasopharyngitis—Capecitabine—stomach cancer	0.00103	0.0138	CcSEcCtD
Epinastine—CYP2B6—endocrine gland—stomach cancer	0.00103	0.00479	CbGeAlD
Epinastine—HTR2A—digestive system—stomach cancer	0.00102	0.00472	CbGeAlD
Epinastine—HRH1—endocrine gland—stomach cancer	0.00101	0.00467	CbGeAlD
Epinastine—ADRA2A—endocrine gland—stomach cancer	0.000989	0.00459	CbGeAlD
Epinastine—ABCB1—hematopoietic system—stomach cancer	0.000959	0.00445	CbGeAlD
Epinastine—CYP3A4—digestive system—stomach cancer	0.000942	0.00437	CbGeAlD
Epinastine—CYP2B6—liver—stomach cancer	0.000929	0.00432	CbGeAlD
Epinastine—Upper respiratory tract infection—Capecitabine—stomach cancer	0.000928	0.0124	CcSEcCtD
Epinastine—CYP2D6—digestive system—stomach cancer	0.000927	0.0043	CbGeAlD
Epinastine—Cough—Irinotecan—stomach cancer	0.000907	0.0121	CcSEcCtD
Epinastine—ABCB1—epithelium—stomach cancer	0.000876	0.00407	CbGeAlD
Epinastine—Mirtazapine—ADRB1—stomach cancer	0.000865	0.0834	CrCbGaD
Epinastine—Infection—Irinotecan—stomach cancer	0.000843	0.0112	CcSEcCtD
Epinastine—HTR2A—endocrine gland—stomach cancer	0.000841	0.0039	CbGeAlD
Epinastine—Rhinitis—Docetaxel—stomach cancer	0.000828	0.011	CcSEcCtD
Epinastine—Pharyngitis—Docetaxel—stomach cancer	0.000819	0.0109	CcSEcCtD
Epinastine—Infection—Fluorouracil—stomach cancer	0.000807	0.0108	CcSEcCtD
Epinastine—Rhinitis—Capecitabine—stomach cancer	0.000801	0.0107	CcSEcCtD
Epinastine—Pharyngitis—Capecitabine—stomach cancer	0.000793	0.0106	CcSEcCtD
Epinastine—ABCB1—pancreas—stomach cancer	0.000781	0.00363	CbGeAlD
Epinastine—CYP3A4—endocrine gland—stomach cancer	0.000778	0.00361	CbGeAlD
Epinastine—Mirtazapine—HTR1A—stomach cancer	0.000773	0.0746	CrCbGaD
Epinastine—CYP2D6—endocrine gland—stomach cancer	0.000766	0.00356	CbGeAlD
Epinastine—HTR2A—liver—stomach cancer	0.000758	0.00352	CbGeAlD
Epinastine—Mirtazapine—ADRB2—stomach cancer	0.000727	0.0701	CrCbGaD
Epinastine—Nasopharyngitis—Epirubicin—stomach cancer	0.00072	0.00959	CcSEcCtD
Epinastine—CYP3A4—liver—stomach cancer	0.000702	0.00326	CbGeAlD
Epinastine—HRH1—lymph node—stomach cancer	0.000696	0.00323	CbGeAlD
Epinastine—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000691	0.0092	CcSEcCtD
Epinastine—CYP2D6—liver—stomach cancer	0.000691	0.00321	CbGeAlD
Epinastine—ADRA2A—lymph node—stomach cancer	0.000684	0.00317	CbGeAlD
Epinastine—ABCB1—lymphoid tissue—stomach cancer	0.000675	0.00313	CbGeAlD
Epinastine—ABCB1—digestive system—stomach cancer	0.000667	0.0031	CbGeAlD
Epinastine—Nasopharyngitis—Doxorubicin—stomach cancer	0.000666	0.00887	CcSEcCtD
Epinastine—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000647	0.00861	CcSEcCtD
Epinastine—Cough—Docetaxel—stomach cancer	0.000627	0.00835	CcSEcCtD
Epinastine—ABCB1—bone marrow—stomach cancer	0.000615	0.00285	CbGeAlD
Epinastine—Cough—Capecitabine—stomach cancer	0.000607	0.00809	CcSEcCtD
Epinastine—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000598	0.00797	CcSEcCtD
Epinastine—Pharyngitis—Methotrexate—stomach cancer	0.000591	0.00786	CcSEcCtD
Epinastine—Infection—Docetaxel—stomach cancer	0.000583	0.00776	CcSEcCtD
Epinastine—Sinusitis—Epirubicin—stomach cancer	0.000582	0.00775	CcSEcCtD
Epinastine—Pruritus—Fluorouracil—stomach cancer	0.000575	0.00766	CcSEcCtD
Epinastine—Mianserin—HTR1A—stomach cancer	0.000568	0.0548	CrCbGaD
Epinastine—Infection—Capecitabine—stomach cancer	0.000564	0.00751	CcSEcCtD
Epinastine—Rhinitis—Epirubicin—stomach cancer	0.000558	0.00743	CcSEcCtD
Epinastine—Pharyngitis—Epirubicin—stomach cancer	0.000553	0.00736	CcSEcCtD
Epinastine—ABCB1—endocrine gland—stomach cancer	0.000551	0.00256	CbGeAlD
Epinastine—Sinusitis—Doxorubicin—stomach cancer	0.000538	0.00717	CcSEcCtD
Epinastine—Headache—Irinotecan—stomach cancer	0.000532	0.00708	CcSEcCtD
Epinastine—Rhinitis—Doxorubicin—stomach cancer	0.000517	0.00688	CcSEcCtD
Epinastine—Pharyngitis—Doxorubicin—stomach cancer	0.000511	0.00681	CcSEcCtD
Epinastine—Headache—Fluorouracil—stomach cancer	0.000509	0.00678	CcSEcCtD
Epinastine—Nortriptyline—HTR1A—stomach cancer	0.000508	0.049	CrCbGaD
Epinastine—ABCB1—liver—stomach cancer	0.000497	0.00231	CbGeAlD
Epinastine—Desipramine—CYP2A6—stomach cancer	0.000481	0.0464	CrCbGaD
Epinastine—Trimipramine—HTR1A—stomach cancer	0.000478	0.0461	CrCbGaD
Epinastine—Desipramine—ADRB1—stomach cancer	0.000468	0.0451	CrCbGaD
Epinastine—Cough—Methotrexate—stomach cancer	0.000452	0.00602	CcSEcCtD
Epinastine—Cough—Epirubicin—stomach cancer	0.000423	0.00563	CcSEcCtD
Epinastine—Infection—Methotrexate—stomach cancer	0.00042	0.00559	CcSEcCtD
Epinastine—Desipramine—HTR1A—stomach cancer	0.000418	0.0404	CrCbGaD
Epinastine—Pruritus—Docetaxel—stomach cancer	0.000415	0.00553	CcSEcCtD
Epinastine—Oxcarbazepine—ALB—stomach cancer	0.000406	0.0392	CrCbGaD
Epinastine—Pruritus—Capecitabine—stomach cancer	0.000402	0.00535	CcSEcCtD
Epinastine—Desipramine—ADRB2—stomach cancer	0.000393	0.0379	CrCbGaD
Epinastine—Infection—Epirubicin—stomach cancer	0.000393	0.00523	CcSEcCtD
Epinastine—Cough—Doxorubicin—stomach cancer	0.000391	0.00521	CcSEcCtD
Epinastine—ABCB1—lymph node—stomach cancer	0.000381	0.00177	CbGeAlD
Epinastine—Headache—Docetaxel—stomach cancer	0.000367	0.00489	CcSEcCtD
Epinastine—Infection—Doxorubicin—stomach cancer	0.000364	0.00484	CcSEcCtD
Epinastine—Headache—Capecitabine—stomach cancer	0.000356	0.00474	CcSEcCtD
Epinastine—Imipramine—HTR1A—stomach cancer	0.000355	0.0342	CrCbGaD
Epinastine—Amitriptyline—HTR1A—stomach cancer	0.000353	0.034	CrCbGaD
Epinastine—Pruritus—Methotrexate—stomach cancer	0.000299	0.00398	CcSEcCtD
Epinastine—Pruritus—Epirubicin—stomach cancer	0.00028	0.00373	CcSEcCtD
Epinastine—Headache—Methotrexate—stomach cancer	0.000265	0.00353	CcSEcCtD
Epinastine—Pruritus—Doxorubicin—stomach cancer	0.000259	0.00345	CcSEcCtD
Epinastine—Headache—Epirubicin—stomach cancer	0.000248	0.0033	CcSEcCtD
Epinastine—Headache—Doxorubicin—stomach cancer	0.000229	0.00305	CcSEcCtD
Epinastine—Nortriptyline—ALB—stomach cancer	0.000228	0.022	CrCbGaD
Epinastine—Amitriptyline—ALB—stomach cancer	0.000158	0.0153	CrCbGaD
Epinastine—CYP2B6—Metabolism—MTHFR—stomach cancer	1.69e-05	8.5e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—ERBB2—stomach cancer	1.69e-05	8.5e-05	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—TP53—stomach cancer	1.69e-05	8.49e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ALDOB—stomach cancer	1.69e-05	8.49e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—FGFR2—stomach cancer	1.69e-05	8.48e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—STAT3—stomach cancer	1.68e-05	8.46e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—FYN—stomach cancer	1.67e-05	8.39e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—CAV1—stomach cancer	1.66e-05	8.37e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—APOA1—stomach cancer	1.66e-05	8.35e-05	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—HRAS—stomach cancer	1.61e-05	8.12e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—MAPK3—stomach cancer	1.61e-05	8.08e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CXCL8—stomach cancer	1.6e-05	8.06e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—HRAS—stomach cancer	1.59e-05	8e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CXCL8—stomach cancer	1.58e-05	7.94e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IRS2—stomach cancer	1.58e-05	7.93e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IRS2—stomach cancer	1.57e-05	7.91e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ALOX5—stomach cancer	1.57e-05	7.89e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—FGFR2—stomach cancer	1.57e-05	7.88e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.56e-05	7.87e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CDKN1B—stomach cancer	1.56e-05	7.87e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—MYC—stomach cancer	1.56e-05	7.86e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—CAV1—stomach cancer	1.56e-05	7.84e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—APOA1—stomach cancer	1.56e-05	7.83e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IRS2—stomach cancer	1.54e-05	7.77e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—DPYD—stomach cancer	1.54e-05	7.76e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—GSTP1—stomach cancer	1.53e-05	7.72e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CAV1—stomach cancer	1.53e-05	7.69e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—MAPK1—stomach cancer	1.53e-05	7.69e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—EGFR—stomach cancer	1.53e-05	7.69e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CAV1—stomach cancer	1.52e-05	7.67e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—APOA1—stomach cancer	1.52e-05	7.67e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—IL6—stomach cancer	1.52e-05	7.66e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—APOA1—stomach cancer	1.52e-05	7.66e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—HMOX1—stomach cancer	1.51e-05	7.62e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CAV1—stomach cancer	1.5e-05	7.53e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—APOA1—stomach cancer	1.49e-05	7.51e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CCND1—stomach cancer	1.49e-05	7.51e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—JUN—stomach cancer	1.49e-05	7.49e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PPP2R1A—stomach cancer	1.47e-05	7.42e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PPARG—stomach cancer	1.46e-05	7.36e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PRKCB—stomach cancer	1.45e-05	7.32e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PRKCB—stomach cancer	1.45e-05	7.3e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL6ST—stomach cancer	1.45e-05	7.29e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MMP9—stomach cancer	1.45e-05	7.29e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GSTP1—stomach cancer	1.45e-05	7.28e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL6ST—stomach cancer	1.45e-05	7.27e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—KRAS—stomach cancer	1.44e-05	7.26e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CDKN1A—stomach cancer	1.44e-05	7.26e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IRS2—stomach cancer	1.43e-05	7.22e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—TYMS—stomach cancer	1.43e-05	7.18e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—HMOX1—stomach cancer	1.43e-05	7.18e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PRKCB—stomach cancer	1.42e-05	7.17e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL6ST—stomach cancer	1.42e-05	7.14e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—GSTM1—stomach cancer	1.41e-05	7.1e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MAPK8—stomach cancer	1.41e-05	7.09e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—APC—stomach cancer	1.39e-05	7e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CAV1—stomach cancer	1.39e-05	7e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—APC—stomach cancer	1.39e-05	6.99e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—APOA1—stomach cancer	1.39e-05	6.98e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PPARG—stomach cancer	1.37e-05	6.9e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GSTT1—stomach cancer	1.36e-05	6.87e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—APC—stomach cancer	1.36e-05	6.86e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.35e-05	6.79e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—TYMS—stomach cancer	1.34e-05	6.77e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—MAPK3—stomach cancer	1.33e-05	6.71e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—MAPK3—stomach cancer	1.33e-05	6.69e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GSTM1—stomach cancer	1.33e-05	6.69e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—ERCC2—stomach cancer	1.33e-05	6.67e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—PIK3CA—stomach cancer	1.33e-05	6.67e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PRKCB—stomach cancer	1.32e-05	6.66e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL6ST—stomach cancer	1.32e-05	6.63e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—ALB—stomach cancer	1.31e-05	6.61e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.31e-05	6.6e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—MAPK3—stomach cancer	1.31e-05	6.57e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—VEGFA—stomach cancer	1.3e-05	6.54e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL6R—stomach cancer	1.29e-05	6.5e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL6R—stomach cancer	1.29e-05	6.49e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—STAT3—stomach cancer	1.29e-05	6.48e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TP53—stomach cancer	1.28e-05	6.45e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ENO1—stomach cancer	1.28e-05	6.43e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—MAPK1—stomach cancer	1.27e-05	6.38e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—EGFR—stomach cancer	1.27e-05	6.38e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—APC—stomach cancer	1.27e-05	6.37e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—MAPK1—stomach cancer	1.27e-05	6.37e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL6R—stomach cancer	1.27e-05	6.37e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—EGFR—stomach cancer	1.27e-05	6.37e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—NOS3—stomach cancer	1.26e-05	6.33e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ERCC2—stomach cancer	1.25e-05	6.29e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—MTHFR—stomach cancer	1.25e-05	6.27e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	1.24e-05	6.25e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	1.24e-05	6.25e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—ALB—stomach cancer	1.23e-05	6.2e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MAPK3—stomach cancer	1.23e-05	6.19e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—HRAS—stomach cancer	1.23e-05	6.17e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	1.21e-05	6.1e-05	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—PIK3CA—stomach cancer	1.21e-05	6.1e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—SERPINE1—stomach cancer	1.21e-05	6.09e-05	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—PIK3CA—stomach cancer	1.21e-05	6.09e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—SERPINE1—stomach cancer	1.21e-05	6.08e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—KRAS—stomach cancer	1.2e-05	6.03e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MYC—stomach cancer	1.2e-05	6.02e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—KRAS—stomach cancer	1.2e-05	6.02e-05	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	1.19e-05	5.97e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	1.19e-05	5.96e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—NOS3—stomach cancer	1.18e-05	5.93e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL6R—stomach cancer	1.18e-05	5.92e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—MTHFR—stomach cancer	1.17e-05	5.91e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IL6—stomach cancer	1.17e-05	5.91e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	1.17e-05	5.9e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MAPK1—stomach cancer	1.17e-05	5.89e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—EGFR—stomach cancer	1.17e-05	5.89e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—RHOA—stomach cancer	1.17e-05	5.88e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—RHOA—stomach cancer	1.17e-05	5.86e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—NOS3—stomach cancer	1.16e-05	5.81e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	1.15e-05	5.81e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	1.15e-05	5.81e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—NOS3—stomach cancer	1.15e-05	5.8e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PTGS2—stomach cancer	1.15e-05	5.79e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—CAV1—stomach cancer	1.15e-05	5.79e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—APOA1—stomach cancer	1.15e-05	5.77e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—RHOA—stomach cancer	1.14e-05	5.75e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CD44—stomach cancer	1.13e-05	5.71e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—NOS3—stomach cancer	1.13e-05	5.69e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—KRAS—stomach cancer	1.11e-05	5.56e-05	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	1.1e-05	5.55e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	1.1e-05	5.54e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	1.1e-05	5.54e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	1.1e-05	5.53e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	1.09e-05	5.48e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—CAV1—stomach cancer	1.08e-05	5.45e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—APOA1—stomach cancer	1.08e-05	5.44e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—ERBB2—stomach cancer	1.08e-05	5.44e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—ERBB2—stomach cancer	1.08e-05	5.43e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PTGS2—stomach cancer	1.08e-05	5.43e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	1.08e-05	5.42e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—RHOA—stomach cancer	1.06e-05	5.35e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	1.06e-05	5.33e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NOS3—stomach cancer	1.05e-05	5.29e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CXCL8—stomach cancer	1.02e-05	5.16e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CXCL8—stomach cancer	1.02e-05	5.15e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—HRAS—stomach cancer	1.02e-05	5.12e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—HRAS—stomach cancer	1.02e-05	5.11e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—PIK3CA—stomach cancer	1.02e-05	5.11e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PPARG—stomach cancer	1.01e-05	5.09e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	1e-05	5.05e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	1e-05	5.04e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	1e-05	5.04e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CDKN1B—stomach cancer	9.99e-06	5.03e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	9.97e-06	5.02e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	9.83e-06	4.95e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TP53—stomach cancer	9.83e-06	4.94e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	9.8e-06	4.93e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—IL6—stomach cancer	9.75e-06	4.9e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—IL6—stomach cancer	9.73e-06	4.89e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	9.64e-06	4.85e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCND1—stomach cancer	9.55e-06	4.81e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—IL6—stomach cancer	9.54e-06	4.8e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—JUN—stomach cancer	9.53e-06	4.8e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCND1—stomach cancer	9.53e-06	4.79e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PPARG—stomach cancer	9.53e-06	4.79e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—JUN—stomach cancer	9.51e-06	4.78e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GSTP1—stomach cancer	9.46e-06	4.76e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—HRAS—stomach cancer	9.4e-06	4.73e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCND1—stomach cancer	9.35e-06	4.71e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—JUN—stomach cancer	9.33e-06	4.7e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—HMOX1—stomach cancer	9.33e-06	4.69e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	9.33e-06	4.69e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MMP9—stomach cancer	9.27e-06	4.67e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	9.26e-06	4.66e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MMP9—stomach cancer	9.25e-06	4.66e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	9.24e-06	4.65e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CDKN1A—stomach cancer	9.22e-06	4.64e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	9.11e-06	4.58e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—ALB—stomach cancer	9.09e-06	4.57e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MMP9—stomach cancer	9.08e-06	4.57e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	9.05e-06	4.55e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MAPK8—stomach cancer	9.02e-06	4.54e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MAPK8—stomach cancer	9e-06	4.53e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IL6—stomach cancer	8.99e-06	4.53e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—IL6—stomach cancer	8.87e-06	4.46e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	8.83e-06	4.44e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—TYMS—stomach cancer	8.79e-06	4.42e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—NOS3—stomach cancer	8.69e-06	4.37e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GSTM1—stomach cancer	8.69e-06	4.37e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCND1—stomach cancer	8.69e-06	4.37e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—JUN—stomach cancer	8.67e-06	4.36e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ALB—stomach cancer	8.56e-06	4.31e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MMP9—stomach cancer	8.43e-06	4.24e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	8.4e-06	4.23e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—VEGFA—stomach cancer	8.32e-06	4.19e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—VEGFA—stomach cancer	8.31e-06	4.18e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—STAT3—stomach cancer	8.24e-06	4.15e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—STAT3—stomach cancer	8.23e-06	4.14e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	8.2e-06	4.13e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—NOS3—stomach cancer	8.19e-06	4.12e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ERCC2—stomach cancer	8.17e-06	4.11e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	8.15e-06	4.1e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—STAT3—stomach cancer	8.07e-06	4.06e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PTGS2—stomach cancer	7.95e-06	4e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MAPK3—stomach cancer	7.88e-06	3.96e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MAPK3—stomach cancer	7.86e-06	3.95e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	7.71e-06	3.88e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—MTHFR—stomach cancer	7.68e-06	3.86e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MYC—stomach cancer	7.66e-06	3.85e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MYC—stomach cancer	7.64e-06	3.85e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	7.57e-06	3.81e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MYC—stomach cancer	7.5e-06	3.77e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—STAT3—stomach cancer	7.5e-06	3.77e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MAPK1—stomach cancer	7.49e-06	3.77e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PTGS2—stomach cancer	7.49e-06	3.77e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—EGFR—stomach cancer	7.49e-06	3.77e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MAPK1—stomach cancer	7.48e-06	3.76e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—EGFR—stomach cancer	7.48e-06	3.76e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	7.34e-06	3.69e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—EGFR—stomach cancer	7.34e-06	3.69e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	7.16e-06	3.61e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CAV1—stomach cancer	7.08e-06	3.56e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—KRAS—stomach cancer	7.08e-06	3.56e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PIK3CA—stomach cancer	7.07e-06	3.56e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—APOA1—stomach cancer	7.07e-06	3.56e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—KRAS—stomach cancer	7.06e-06	3.55e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MYC—stomach cancer	6.97e-06	3.51e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—KRAS—stomach cancer	6.93e-06	3.49e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	6.82e-06	3.43e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EGFR—stomach cancer	6.82e-06	3.43e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3CA—stomach cancer	6.63e-06	3.34e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	6.5e-06	3.27e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3CA—stomach cancer	6.49e-06	3.26e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—KRAS—stomach cancer	6.44e-06	3.24e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	6.37e-06	3.2e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TP53—stomach cancer	6.29e-06	3.17e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TP53—stomach cancer	6.28e-06	3.16e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PPARG—stomach cancer	6.23e-06	3.13e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TP53—stomach cancer	6.16e-06	3.1e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—HRAS—stomach cancer	6.02e-06	3.03e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—HRAS—stomach cancer	6e-06	3.02e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	5.92e-06	2.98e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—HRAS—stomach cancer	5.89e-06	2.96e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL6—stomach cancer	5.76e-06	2.9e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL6—stomach cancer	5.75e-06	2.89e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TP53—stomach cancer	5.72e-06	2.88e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL6—stomach cancer	5.64e-06	2.84e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ALB—stomach cancer	5.6e-06	2.82e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—HRAS—stomach cancer	5.47e-06	2.75e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NOS3—stomach cancer	5.36e-06	2.7e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL6—stomach cancer	5.24e-06	2.64e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PTGS2—stomach cancer	4.9e-06	2.47e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3CA—stomach cancer	4.89e-06	2.46e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3CA—stomach cancer	4.61e-06	2.32e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.01e-06	1.52e-05	CbGpPWpGaD
